
- •November 16, 2002
- •February 14, 2003
- •February 21
- •February 28
- •March 7
- •March 10
- •March 12
- •March 14
- •March 15
- •March 17
- •March 19
- •March 21
- •March 24
- •March 26
- •March 28
- •March 30
- •March 31
- •April 2
- •April 2
- •April 8-10
- •April 12
- •April 16
- •April 20
- •April 20
- •April 23
- •April 25
- •April 27
- •April 29
- •June 6
- •June 13
- •June 17
- •June 21
- •June 23
- •June 24
- •July 2
- •July 5
- •August 14
- •September 8
- •September 24
- •References
- •Virology
- •Discovery of the SARS Virus
- •Initial Research
- •The Breakthrough
- •Coronaviridae
- •SARS Co-V
- •Genome Sequence
- •Morphology
- •Organization
- •Detection
- •Stability and Resistance
- •Natural Host
- •Antiviral Agents and Vaccines
- •Antiviral Drugs
- •Vaccines
- •Outlook
- •References
- •Routes of Transmission
- •Factors Influencing Transmission
- •Patient Factors in Transmission
- •Asymptomatic Patients
- •Symptomatic Patients
- •Superspreaders
- •The Unsuspected Patients
- •High-Risk Activities
- •Transmission during Quarantine
- •Transmission after Recovery
- •Animal Reservoirs
- •Conclusion
- •References
- •Introduction
- •Modeling the Epidemic
- •Starting Point
- •Global Spread
- •Hong Kong
- •Vietnam
- •Toronto
- •Singapore, February 2003
- •China
- •Taiwan
- •Other Countries
- •Eradication
- •Outlook
- •References
- •Introduction
- •International Coordination
- •Advice to travelers
- •Management of SARS in the post-outbreak period
- •National Measures
- •Legislation
- •Extended Case Definition
- •Quarantine
- •Reduce travel between districts
- •Quarantine after Discharge
- •Infection Control in Healthcare Settings
- •General Measures
- •Protective Measures
- •Hand washing
- •Gloves
- •Face Masks
- •Additional protection
- •Getting undressed
- •Special Settings
- •Intensive Care Units
- •Intubating a SARS Patient
- •Anesthesia
- •Triage
- •Internet Sources
- •Additional information
- •Infection Control in Households
- •Possible Transmission from Animals
- •After the Outbreak
- •Conclusion
- •References
- •Case Definition
- •WHO Case Definition
- •Suspect case
- •Probable case
- •Exclusion criteria
- •Reclassification of cases
- •CDC Case Definition
- •Diagnostic Tests
- •Introduction
- •Laboratory tests
- •Molecular tests
- •Virus isolation
- •Antibody detection
- •Interpretation
- •Limitations
- •Biosafety considerations
- •Outlook
- •Table, Figures
- •References
- •Clinical Presentation and Diagnosis
- •Clinical Presentation
- •Hematological Manifestations
- •Atypical Presentation
- •Chest Radiographic Abnormalities
- •Chest Radiographs
- •CT Scans
- •Diagnosis
- •Clinical Course
- •Viral Load and Immunopathological Damage
- •Histopathology
- •Lung Biopsy
- •Postmortem Findings
- •Discharge and Follow-up
- •Psychosocial Issues
- •References
- •Appendix: Guidelines
- •WHO: Management of Severe Acute Respiratory Syndrome (SARS)
- •Management of Suspect and Probable SARS Cases
- •Definition of a SARS Contact
- •Management of Contacts of Probable SARS Cases
- •Management of Contacts of Suspect SARS Cases
- •SARS Treatment
- •Antibiotic therapy
- •Antiviral therapy
- •Ribavirin
- •Neuraminidase inhibitor
- •Protease inhibitor
- •Human interferons
- •Human immunoglobulins
- •Alternative medicine
- •Immunomodulatory therapy
- •Corticosteroids
- •Other immunomodulators
- •Assisted ventilation
- •Non-invasive ventilation
- •Invasive mechanical ventilation
- •Clinical outcomes
- •Outlook
- •Appendix 1
- •A standardized treatment protocol for adult SARS in Hong Kong
- •Appendix 2
- •A treatment regimen for SARS in Guangzhou, China
- •References
- •Pediatric SARS
- •Clinical Manifestation
- •Radiologic Features
- •Treatment
- •Clinical Course
- •References

128 Clinical Presentation and Diagnosis
Thus, atypical presentations of SARS are a threat to patients, staff, and visitors. The WHO case definition is a useful epidemiological device; however, it is no substitute for daily, thorough clinical, laboratory, and radiological assessment of patients with symptoms of SARS (Fisher).
Table 3: Characteristics of four patients with atypical presentations of SARS*
|
Patient 1 |
Patient 2 |
Patient 3 |
Patient 4 |
Age (years) |
71 |
43 |
78 |
63 |
Time to isola- |
3 |
8 |
4 |
12 |
tion (h) |
|
|
|
|
Temperature |
38.7 |
37.3 |
36.3 |
36.0 |
on admission |
|
|
|
|
(°C) |
|
|
|
|
WBC (109/L) |
4.5 |
19.3 |
11.2 |
9.3 |
Lymphocytes |
0.78 |
0.94 |
0.69 |
0.63 |
(109/L) |
|
|
|
|
LDH (IU/L) |
747 |
2513 |
1032 |
1770 |
Initial diagno- |
Possible |
Pneumonia |
Exacerbation |
Congestive |
sis |
congestive |
bilateral, |
of chronic |
cardiac failure |
|
cardiac failure |
possibly |
lung disease, |
|
|
|
bacterial |
possible |
|
|
|
|
congestive |
|
|
|
|
cardiac failure |
|
Co- |
Diabetes, |
Hypertension |
Connective |
Ischemic |
morbidities |
ischemic |
|
tissue disease |
heart disease |
|
heart disease |
|
on steroids, |
|
|
|
|
ischemic |
|
|
|
|
heart disease |
|
Outcome |
Survived |
Died |
Died |
Died |
* modified from Fisher et al.
Chest Radiographic Abnormalities
Imaging plays an important role in the diagnosis of SARS and monitoring of response to therapy. A predominant peripheral location, a progression pattern from unilateral focal air-space opacity to unilateral multifocal or bilateral involvement during treatment, and lack of cavitation, lymphadenopathy, and pleural effusion are the more distinctive radiographic findings (Wong 2003b).
www.SARSreference.com
Chest Radiographic Abnormalities 129
Chest Radiographs
At the onset of fever, 70-80 % of the patients have abnormal chest radiographs (Booth, Wong 2003b, Peiris 2003b). It should be noted that, in a substantial proportion of cases, chest radiographs may be normal during the febrile prodrome, as well as throughout the course of illness. In other cases, radiological evidence of pneumonic changes may precede the fever (Rainer), particularly in individuals with comorbidities who may be impaired in their ability to mount a fever (Fisher 2003a).
Chest X-ray findings typically begin with a small, unilateral, patchy shadowing, and progress over 1-2 days to become bilateral and generalized, with interstitial or confluent infiltrates. Air-space opacities eventually develop during the course of the disease. In patients who deteriorate clinically, the air-space opacities may increase in size, extent, and severity (Tsang, Lee).
In the first large cohort from Hong Kong, 55 % of the patients had unilateral focal involvement and 45 % had either unilateral multi-focal or bilateral involvement at the onset of fever (Lee). Within a prospective cohort, initial involvement was confined to one lung zone in 49% and was multi-zonal in 21% of the patients (Peiris 2003b).
The initial radiographic changes may be indistinguishable from those associated with other causes of bronchopneumonia. The research group from Hong Kong suggested that chest radiographs might offer important diagnostic clues, in particular when, after approximately one week, unilateral, predominantly peripheral areas of consolidation progress to bilateral patchy consolidation, and when the extent of the lung opacities is correlated with the deterioration in respiratory function (Lee).
There seems to be a predominant involvement of the peripheral-zone. Pleural effusions, cavitation, and hilar lymphadenopathy are usually absent. Respiratory symptoms and positive auscultatory findings are disproportionally mild compared with the chest radiographic findings (Lee).
One large study focused on radiographic appearances and the pattern of progression (Wong 2003b). Within this cohort of 138 patients, four patterns of radiographic progression were recognized: type 1 (initial
Kamps and Hoffmann (eds.)
130 Clinical Presentation and Diagnosis
radiographic deterioration to a peak level, followed by radiographic improvement) in 70.3%, type 2 (fluctuating radiographic changes) in 17.4%, type 3 (static radiographic appearance) in 7.3%, and type 4 (progressive radiographic deterioration) in 5.1% of the patients. Findings during deterioration are compatible with the radiological features of acute respiratory distress syndrome.
CT Scans
The predominant abnormalities found on initial CT scans are areas of sub-pleural focal consolidation with air bronchograms and groundglass opacities (Tsang). The lower lobes are preferentially affected, especially in the early stages. Patients with more advanced cases show a more bilateral involvement (Wong 2003a). The lesions tend to be peripheral and smaller in the less severely affected lungs, also suggesting an earlier stage of the disease. In patients with more advanced cases, there is involvement of the central, perihilar regions by larger (>3 cm) lesions. The majority of the lesions contained an area of ground-glass opacification with or without consolidation. Other findings include intralobular thickening, interlobular septal thickening, a crazy-paving pattern, and bronchiectasis (Wong 2003a). Obvious bronchial dilatation is generally not found (Lee).
Radiographically, SARS may be indistinguishable from other severe forms of pneumonia. It also shares CT features with other conditions that result in subpleural air-space disease, such as the pneumonia of bronchiolitis obliterans and acute interstitial pneumonia (Tsang).
Radiologists from the Prince of Wales Hospital, Hong Kong, recommend the following protocol for diagnostic imaging of suspected SARS patients (Wong 2003a):
a)Patients with symptoms and signs consistent with SARS and with abnormalities on chest radiographs are followed up with serial radiography. CT scanning is not required for diagnosis.
b)Patients with symptoms and signs consistent with SARS and with a normal chest radiograph undergo thin-section CT to confirm the diagnosis. They subsequently undergo serial radiography for follow-up.
www.SARSreference.com